Efficacy and Safety Evaluation of Neobianacid® in GERD and EPS
Phase 4
Completed
- Conditions
- GERDEPS
- Interventions
- First Posted Date
- 2017-08-03
- Last Posted Date
- 2022-11-21
- Lead Sponsor
- Aboca Spa Societa' Agricola
- Target Recruit Count
- 275
- Registration Number
- NCT03238534
- Locations
- 🇮🇹
Azienda Ospedaliera Perugia, Perugia, Italy
🇮🇹Ospedale Sandro Pertini, Rome, Italy
🇮🇹Ospedale San Giovanni Addolorata, Rome, Italy
Effectiveness & Safety of Promelaxin® Microenemas Against Macrogol 4000 P.O. in Chronic Constipation in Children 6-48 Months
Phase 4
Completed
- Conditions
- Chronic Functional Constipation
- Interventions
- Device: micro-enema with PromelaxinDrug: Macrogol 4000
- First Posted Date
- 2016-04-26
- Last Posted Date
- 2020-05-29
- Lead Sponsor
- Aboca Spa Societa' Agricola
- Target Recruit Count
- 158
- Registration Number
- NCT02751411
- Locations
- 🇮🇹
ASL 1 Avezzano Sulmona L'Aquila - Ospedale San Salvatore - UO Clinica Pediatrica - Località Coppito, L'Aquila, AQ, Italy
🇮🇹Fondazione IRCCS Policlinico San Matteo di Pavia- Dipartimento Scienze Clinico-Chirurgiche, Diagnostiche e Pediatriche - Viale Golgi, 19, Pavia, PV, Italy
🇮🇹Dipartimento di Scienze Mediche Traslazionali - Pediatria - Università Federico II, Napoli, Italy
Evaluation of the Efficacy and Tolerability of ABO/MEG-B-09 in Children With Acute Cough
Phase 3
Completed
- Conditions
- Cough
- Interventions
- Device: AboMeg-B-09Other: Placebo
- First Posted Date
- 2010-12-14
- Last Posted Date
- 2014-12-02
- Lead Sponsor
- Aboca Spa Societa' Agricola
- Target Recruit Count
- 102
- Registration Number
- NCT01259674
- Locations
- 🇮🇹
Santa Maria della Misercordia di Udine Hospital, Udine, Italy
© Copyright 2025. All Rights Reserved by MedPath